Your session is about to expire
← Back to Search
Observational for Sarcoma (CAUSAL Trial)
N/A
Recruiting
Led By Debra Friedman, MD
Research Sponsored by Vanderbilt-Ingram Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately six years
Awards & highlights
Summary
This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately six years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately six years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Impact of disease on adverse oncologic outcomes
Impact of lifestyle contributors on adverse oncologic outcomes
Impact of sociodemographic contributors on adverse oncologic outcomes
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment7 Interventions
Patients monitor physical activity, sedentary behavior, heart rate and sleep wearing a FitBit device, undergo blood urine, stool and/or saliva sample collection, complete surveys and have medical records reviewed throughout study.
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,841 Previous Clinical Trials
41,000,715 Total Patients Enrolled
459 Trials studying Sarcoma
232,307 Patients Enrolled for Sarcoma
Vanderbilt-Ingram Cancer CenterLead Sponsor
215 Previous Clinical Trials
60,955 Total Patients Enrolled
2 Trials studying Sarcoma
46 Patients Enrolled for Sarcoma
Debra Friedman, MDPrincipal InvestigatorVanderbilt University/Ingram Cancer Center
4 Previous Clinical Trials
1,775 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger